Evidence map›Paper›PMID 25439778›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2015

C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3.

Daine T Bennett, Thomas Brett Reece, Lisa S Foley, Ayla Sjoberg, Xianzhong Meng, David A Fullerton, Michael J Weyant

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The role of tensins in malignant neoplasms.Archives of medical science : AMS · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Daine T BennettDivision of Cardiothoracic Surgery, Department of Surgery, University of Colorado Denver, School of Medicine, Aurora, Colo.
Thomas Brett ReeceDivision of Cardiothoracic Surgery, Department of Surgery, University of Colorado Denver, School of Medicine, Aurora, Colo.
Lisa S FoleyDivision of Cardiothoracic Surgery, Department of Surgery, University of Colorado Denver, School of Medicine, Aurora, Colo.
Ayla SjobergDivision of Cardiothoracic Surgery, Department of Surgery, University of Colorado Denver, School of Medicine, Aurora, Colo.
Xianzhong MengDivision of Cardiothoracic Surgery, Department of Surgery, University of Colorado Denver, School of Medicine, Aurora, Colo.
David A FullertonDivision of Cardiothoracic Surgery, Department of Surgery, University of Colorado Denver, School of Medicine, Aurora, Colo.
Michael J WeyantDivision of Cardiothoracic Surgery, Department of Surgery, University of Colorado Denver, School of Medicine, Aurora, Colo. Electronic address: michael.weyant@ucdenver.edu.
University of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Tissue Bank and Biomarkers CoreP50CA058187 · NCI · UNIVERSITY OF COLORADO DENVER · PI MILLER, YORK E · 1992 to 2018
$43.8M
NCI NIH HHS P30 CA046934NCI NIH HHS P50 CA058187
6 · The paper itself

Abstract

objectivesC-terminal tensin-like (Cten) protein, a component of focal adhesions, contributes to cell motility and invasion in multiple human cancers. Epidermal growth factor can activate signal transducer and activator of transcription 3, and both contribute to invasion through focal adhesion interactions. We hypothesize that Cten may mediate invasion of lung cancer cells provided by epidermal growth factor via signal transducer and activator of transcription 3.

methodsFour human non-small cell lung cancer cell lines were treated with epidermal growth factor to evaluate activation of the signal transducer and activator of transcription 3 pathway and induction of Cten expression. Chemical inhibition of signal transducer and activator of transcription 3 was used to evaluate the effect on epidermal growth factor-induced Cten expression. Protein expression was quantified by Western blot. H125 and A549 cells were transduced with short-hairpin RNA via lentiviral vector to knockdown expression of Cten. An in vitro transwell invasion assay was used to assess the effects of Cten knockdown on cell invasion (n = 3 for all experiments).

resultsStimulation of lung cancer cells with epidermal growth factor activated the signal transducer and activator of transcription 3 pathway and induced expression of Cten in all cell lines. Signal transducer and activator of transcription 3 inhibition significantly reduced epidermal growth factor-induced expression of Cten in H125 (P < .0001), H358 (P = .006), and H441 (P = .014) cells in a dose-dependent manner. Knockdown of Cten expression resulted in significant decreases in cellular invasion in both H125 (P = .0036) and A549 (P = .0006) cells.

conclusionsThese are the first findings in lung cancer to demonstrate that Cten expression mediates invasion of human lung cancer cells and is upregulated by epidermal growth factor via signal transducer and activator of transcription 3 pathway. Cten should be considered a potential therapeutic target for lung cancer.

Indexed as

Cell MovementAminosalicylic AcidsBenzenesulfonatesCarcinoma, Non-Small-Cell LungCell Line, TumorDose-Response Relationship, DrugEpidermal Growth FactorHumansLung NeoplasmsMicrofilament ProteinsNeoplasm InvasivenessRNA InterferenceSignal TransductionSTAT3 Transcription FactorTensinsTime FactorsAminosalicylic AcidsBenzenesulfonatesEpidermal Growth FactorMicrofilament ProteinsNSC 74859STAT3 protein, humanSTAT3 Transcription FactorTensinsTNS4 protein, human

Identifiers

PMID25439778
PMCPMC4730942
OpenAlexW2073641059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.